MSLE
MSLE clinical trials: Satellos Bioscience Inc.
Every trial on ClinicalTrials.gov where Satellos Bioscience Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MSLE on the catalyst calendar · MSLE registry changes
- Primary completion Sep 30, 2027Sponsor estimatePhase 2NCT06867107An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated...Satellos Bioscience, Inc. · Duchenne Muscular Dystrophy (DMD)RecruitingMSLELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2028Sponsor estimatePhase 2NCT07872306A Study of SAT-3247 to Evaluate the Safety, Tolerability, and Efficacy in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)Satellos Bioscience, Inc. · Facioscapulohumeral Muscular Dystrophy (FSHD)Not yet recruitingMSLELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2027Sponsor estimatePhase 2NCT07287189Phase 2 Study of SAT-3247 in Pediatric Ambulatory PatientsSatellos Bioscience, Inc. · Duchenne Muscular DystrophyActive, not recruitingMSLELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 28, 2025ActualEarly Phase 1NCT06565208First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK CohortSatellos Bioscience, Inc. · Duchenne Muscular DystrophyCompletedMSLELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner